Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
33
NCT03406962
MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 9, 2018
Completion: Jan 15, 2021
NCT04008849
A Follow-up Study in Patients With Inherited Metabolic Disorders (IMD) Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) With MGTA-456
Phase: N/A
Start: May 21, 2019
Completion: Oct 8, 2020
NCT05223699
Study of MGTA-117 in Patients With Adult Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts (MDS-EB)
Phase: Phase 1
Start: Feb 14, 2022
Completion: Feb 2, 2023